BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Press Releases

  AIRNA Presents New Preclinical Data on AATD Therapeutic Candidate AIR-001 and Cardiometabolic RNA-Editing Programs at ASGCT

  May 12, 2026

   · 

  5 min read
• Press Releases

  Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

  May 12, 2026

   · 

  7 min read
• Press Releases

  MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026

  May 12, 2026

   · 

  5 min read
• Press Releases

  IMMEDIATE Therapeutics adds Industry and Scientific Leaders to Advance IMT-358 Breakthrough Ischemic Therapy

  May 12, 2026

   · 

  5 min read
• Press Releases

  BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1

  May 12, 2026

   · 

  8 min read
• Press Releases

  ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million

  May 12, 2026

   · 

  1 min read
• Press Releases

  Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference

  May 12, 2026

   · 

  2 min read
• Press Releases

  BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

  May 12, 2026

   · 

  4 min read
• Press Releases

  Compass Therapeutics to Participate in Upcoming May 2026 Investor Events

  May 12, 2026

   · 

  1 min read
• Press Releases

  Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

  May 12, 2026

   · 

  13 min read